Sources | Names Used |
---|---|
CTRPv2 | YL54 |
PharmacoGx | YL54 |
Database | Identifier |
---|---|
Smiles: | CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CCNC(C)=O)C(=O)N[C@]1(C)CCCC=C/CCC[C@@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OR13C9 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | UHRF1BP1L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | REPIN1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | SERINC3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | GRM1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | AZU1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | OTC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | HLA-DOB | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | CHRD | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | RNF144B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |